ES2059399T3 - Uso de derivados heterociclicos en la fabricacion de medicamentos. - Google Patents

Uso de derivados heterociclicos en la fabricacion de medicamentos.

Info

Publication number
ES2059399T3
ES2059399T3 ES87311081T ES87311081T ES2059399T3 ES 2059399 T3 ES2059399 T3 ES 2059399T3 ES 87311081 T ES87311081 T ES 87311081T ES 87311081 T ES87311081 T ES 87311081T ES 2059399 T3 ES2059399 T3 ES 2059399T3
Authority
ES
Spain
Prior art keywords
medicines
manufacture
cyclic derivatives
hetero cyclic
hetero
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87311081T
Other languages
English (en)
Spanish (es)
Inventor
Michael Brian Tyers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ES2059399T3 publication Critical patent/ES2059399T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES87311081T 1986-12-17 1987-12-16 Uso de derivados heterociclicos en la fabricacion de medicamentos. Expired - Lifetime ES2059399T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868630080A GB8630080D0 (en) 1986-12-17 1986-12-17 Medicaments

Publications (1)

Publication Number Publication Date
ES2059399T3 true ES2059399T3 (es) 1994-11-16

Family

ID=10609121

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87311081T Expired - Lifetime ES2059399T3 (es) 1986-12-17 1987-12-16 Uso de derivados heterociclicos en la fabricacion de medicamentos.

Country Status (10)

Country Link
EP (1) EP0272876B1 (da)
JP (1) JPS63246337A (da)
AT (1) ATE95704T1 (da)
AU (1) AU618943B2 (da)
CA (1) CA1314223C (da)
DE (1) DE3787796T2 (da)
DK (1) DK662487A (da)
ES (1) ES2059399T3 (da)
GB (1) GB8630080D0 (da)
ZA (1) ZA879459B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
WO1993012817A1 (en) * 1991-12-20 1993-07-08 Warner-Lambert Company Therapeutic combinations useful in the treatment of gastroesophageal reflux disease
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
GB9312315D0 (en) * 1993-06-15 1993-07-28 Poston Robin Leukocyte adhesion assay
CZ289804B6 (cs) * 1994-07-08 2002-04-17 Astrazeneca Ab Multijednotková tabletovaná dávková forma I
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
WO1997047285A1 (en) * 1996-06-10 1997-12-18 Depomed, Inc. Gastric-retentive oral controlled drug delivery system with enhanced retention properties
SE0203410D0 (sv) * 2002-11-18 2002-11-18 Astrazeneca Ab New use
MXPA05011699A (es) * 2003-05-06 2006-01-23 Altana Pharma Ag Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
GB2161160B (en) * 1984-07-06 1989-05-24 Fisons Plc Heterocyclic sulphinyl compounds
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
DE3771376D1 (de) * 1986-03-17 1991-08-22 Glaxo Group Ltd Indol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Also Published As

Publication number Publication date
DK662487D0 (da) 1987-12-16
EP0272876A2 (en) 1988-06-29
DK662487A (da) 1988-06-18
DE3787796T2 (de) 1994-03-03
ATE95704T1 (de) 1993-10-15
JPS63246337A (ja) 1988-10-13
CA1314223C (en) 1993-03-09
GB8630080D0 (en) 1987-01-28
EP0272876B1 (en) 1993-10-13
ZA879459B (en) 1988-11-30
EP0272876A3 (en) 1988-07-27
AU618943B2 (en) 1992-01-16
DE3787796D1 (de) 1993-11-18
AU8261587A (en) 1988-06-23

Similar Documents

Publication Publication Date Title
BG60249B2 (en) Thiazole compound for treatment of ulcers
NO884623D0 (no) Fremgangsmaate for fremstilling av silisiumkarbid.
FR2624720B1 (fr) Implant pour dispositif d'osteosynthese, notamment du rachis
NO930817L (no) Imidazolderivater med bifenylsulfonylurea- eller bifenylsulfonyluretan-sidekjeder, fremgangsmaate for deres fremstilling og deres anvendelse
IT8867014A0 (it) Dispositivo protesico per la correzione chirurgica dell insufficenza tricuspidale
DK0386675T3 (da) Xanthinderivater
ES2074981T3 (es) Uso de derivados heterociclicos en el tratamiento de trastornos cognoscitivos.
IT1206773B (it) Dispositivo per la regolazione della trazione del nastro d'ordito durante la formazione dell'ordito.
SE8503207L (sv) Farmakologiskt aktiva substituerade bensamider
SE8301008L (sv) Pyrrolacetamider med antiinflammatorisk verkan
DK662487D0 (da) Medikamenter
ES556864A0 (es) Procedimiento para la obtencion de benzopiranos sustituidos.
FI94354C (fi) Menetelmä farmaseuttisesti aktiivisten peptidien valmistamiseksi
KR920700625A (ko) 고혈압 치료를 위한 신장에 선택적인 프로드러그(Prodrug)
ATE87333T1 (de) Rezeptor der kleinen rhinovirus rezeptor gruppe.
ES2132245T3 (es) Derivados de 1-azaadamantano como agonistas o antagonistas de 5-ht.
NO864397D0 (no) Fremgangsmaate for fremstilling av siliciumcarbid.
ES532125A0 (es) Un procedimiento de preparacion de nuevas formas galenicas de n-(etil-1-pirrolidinil-2-)-metil-metoxi-2-sulfamoil-5-benzamida, utilizables por via oral
ATE81016T1 (de) Anwendung heterozyklischer dervate zur herstellung von arzneimitteln.
ATE113949T1 (de) Alpha-adrenergische rezeptorantagonisten.
ES2088567T3 (es) Empleo de derivados de la 2-iminotioazolidin-4-ona como nuevos productos activos para medicamentos.
PT78155A (de) N-(3-trifluormethylphenyl)-n'-propargylpiperazin seine herstellung und verwendung
DK0382380T3 (da) Pyrimidiniumnitrat, fremstilling og anvendelse heraf
IT8047950A0 (it) Composizioni farmaceutiche impiegabili per il trattamento dell'ipertensione
ES2063890T3 (es) Derivados y analogos de monoetilglicinaxilidina y su produccion y uso.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 272876

Country of ref document: ES